Stockreport

Precision Therapeutics Subsidiary, TumorGenesis, Announces License Agreement with 48Hour Discovery

PRECISION THERAPEUTICS INC COMMON  (AIPT) 
US:NASDAQ Investor Relations: investors.skylinemedical.com/investor-relations
PDF MINNEAPOLIS, March 15, 2018 (GLOBE NEWSWIRE) -- Precision Therapeutics Inc. (NASDAQ:AIPT) (“Precision” or “the Company”), formerly Skyline Medical, announced today tha [Read more]